e-learning
resources
Paris 2018
Wednesday, 19.09.2018
What is new in idiopathic interstitial pneumonias?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Dehydroepiandrosterone sulfate plasma levels correlate with lung function, muscle mass and physical performance in fibrotic interstitial lung disease
S. Guler (Vancouver, Canada), S. Hur (Vancouver, Canada), S. Lear (Burnaby, Canada), P. Camp (Vancouver, Canada), P. Wilcox (Vancouver, Canada), J. Leung (Vancouver, Canada), C. Ryerson (Vancouver, Canada)
Source:
International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Session:
What is new in idiopathic interstitial pneumonias?
Session type:
Poster Discussion
Number:
5234
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Guler (Vancouver, Canada), S. Hur (Vancouver, Canada), S. Lear (Burnaby, Canada), P. Camp (Vancouver, Canada), P. Wilcox (Vancouver, Canada), J. Leung (Vancouver, Canada), C. Ryerson (Vancouver, Canada). Dehydroepiandrosterone sulfate plasma levels correlate with lung function, muscle mass and physical performance in fibrotic interstitial lung disease. 5234
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
Dehydroepiandrosterone sulfate plasma levels correlate with lung function in patients with fibrotic interstitial lung disease in two independent cohorts.
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019
Total desmosines in plasma and urine correlate with lung function
Source: Eur Respir J 2012; 39: 839-845
Year: 2012
Correlation of physical fitness with peripheral muscle strength, physical activity levels and lung function in patients with cystic fibrosis
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018
Short-term dynamic lung function and predictors of lung function decline in systemic sclerosis-related interstitial lung disease
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Increased tumour necrosis factor-α plasma levels during moderate-intensity exercise in COPD patients
Source: Eur Respir J 2003; 21: 789-794
Year: 2003
The effect of corticosteroid use on skeletal muscle function in patients with interstitial lung disease
Source: Annual Congress 2012 - The latest insights in integrated care
Year: 2012
KL-6, SP-D and MMP-7 as serum biomarkers for early detection of interstitial lung diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Does lung function predict response to therapy in PAH associated with connective tissue disease?
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012
Relationship between the tissue depletion pattern and muscle mass, muscle strength and inflammation in COPD patients
Source: Annual Congress 2006 - COPD and systemic inflammation
Year: 2006
Corticosteroids affect skeletal muscle strength in mild level of breathlessness of patients with interstitial lung disease
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Effect of pulmonary rehabilitation on systemic inflammatory markers, muscle cross section area and functional parameters in interstitial lung disease
Source: Annual Congress 2012 - New issues in pulmonary function
Year: 2012
Serum surfactant protein D is a potential biomarker of lung damage in systemic sclerosis
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Beyond the lungs in fibrotic interstitial lung disease: does supplemental O2 improve skeletal muscle oxygenation and fatigue?
Source: Virtual Congress 2020 – Exploring respiratory function
Year: 2020
Identifying serum molecular biomarkers that distinguish emphysema and early fibrotic interstitial lung disease.
Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
Year: 2021
Differences in cellular expression of C-reactive protein and serum amyloid A in lung tissue in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012
Nintedanib inhibits contractile activity of lung myofibroblasts in a cellular model of scleroderma associated pulmonary fibrosis
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018
Scleroderma lung disease: A scleroderma physiologic index (SPI) derived from lung physiology and oxygen saturation
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Aerobic exercise can impair lung fibrotic and functional response in a model of bleomycin-induced lung fibrosis: a time-dependent effect
Source: International Congress 2017 – Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis
Year: 2017
Respiratory muscle function in interstitial lung disease
Source: Eur Respir J 2013; 42: 211-219
Year: 2013
Exercise tolerance in interstitial and chest wall disorders
Source: Annual Congress 2005 - Mechanical factors limiting physical exercise in disease
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept